Chemotherapy versus allogeneic transplantation for very-high-risk childhood acute lymphoblastic leukaemia in first complete remission: Comparison by genetic randomisation in an international prospective study

Lancet

Volumn 366, Issue 9486, 2005, Pages 635-642

  Balduzzi, Adriana ^a   Valsecchi, Maria Grazia ^a   Uderzo, Cornelio ^a   De Lorenzo, Paola ^a   Klingebiel, Thomas ^b   Peters, Christina ^c   Stary, Jan ^d   Felice, Maria S ^e   Magyarosy, Edina ^f   Conter, Valentino ^a   Reiter, Alfred ^g   Messina, Chiara ^h   Gadner, Helmut ^c   Schrappe, Martin ⁱ  

^a UNIVERSITY OF MILANO BICOCCA   (Italy)

^b GOETHE UNIVERSITY   (Germany)

^c ST ANNA CHILDREN S HOSPITAL   (Austria)

^d UNIVERSITY HOSPITAL MOTOL   (Czech Republic)

^e HOSPITAL DE PEDIATRÍA PROF DR JUAN P GARRAHAN   (Argentina)

^f SEMMELWEIS UNIVERSITY OF MEDICINE   (Hungary)

^g JUSTUS LIEBIG UNIVERSITY   (Germany)

^h UNIVERSITY OF PADOVA   (Italy)

ⁱ UNIVERSITY HOSPITAL SCHLESWIG HOLSTEIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ASPARAGINASE; BUSULFAN; CYCLOPHOSPHAMIDE; CYCLOSPORIN; ETOPOSIDE; METHOTREXATE; PREDNISONE;

ACUTE LYMPHOBLASTIC LEUKEMIA; ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION; ARTICLE; CANCER CHEMOTHERAPY; CANCER RISK; CANCER SURVIVAL; CHILD; CHILDHOOD CANCER; CLINICAL TRIAL; CLONAL VARIATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DONOR; DRUG RESPONSE; FEMALE; GENETICS; GRAFT VERSUS HOST REACTION; HIGH RISK POPULATION; HUMAN; IMMUNOPHENOTYPING; INTERMETHOD COMPARISON; LEUKEMIA REMISSION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RISK ASSESSMENT; T LYMPHOCYTE; TREATMENT OUTCOME;

EID: 23844556272     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(05)66998-X     Document Type: Article

References (32)

1. CH Pui, WE Evans Acute lymphoblastic leukemia N Engl J Med 339 1998 605 615
2. JM Chessells, SM Richards, CC Bailey, JS Lilleyman, OB Eden Gender and treatment outcome in childhood lymphoblastic leukaemia: report from the MRC UKALL trials Br J Haematol 89 1995 364 372
3. LB Silverman, RD Gelber, VK Dalton Improved outcome for children with acute lymphoblastic leukemia: results of Dana Farber Consortium Protocol 91-01 Blood 97 2001 1211 1218
4. M Schrappe, A Reiter, WD Ludwig Improved outcome in childhood acute lymphoblastic leukemia despite reduced use of anthracyclines and cranial radiotherapy: results of trial ALL-BFM 90 German-Austrian-Swiss ALL-BFM Study Group Blood 95 2000 3310 3322
5. V Conter, M Aricò, MG Valsecchi Intensive BFM chemotherapy for childhood ALL: interim analysis of the AIEOP-ALL91 study: Associazione Italiana Ematologia Oncologia Pediatrica Haematologica 83 1998 791 799
6. PS Gaynon, PG Steinherz, WA Bleyer Improved therapy for children with acute lymphoblastic leukemia and unfavourable presenting features: a follow-up report of the Children's Cancer Group Study CCG-106 J Clin Oncol 11 1993 2234 2242
7. M Schrappe, M Aricò, J Harbott Philadelphia chromosome-positive (Ph+) childhood acute lymphoblastic leukaemia: good initial steroid response allows early prediction of a favourable treatment outcome Blood 92 1998 2730 2741
8. FM Uckun, JB Nachman, HN Sather Clinical significance of Philadelphia chromosome positive pediatric acute lymphoblastic leukemia in the context of contemporary intensive therapies: a report from the Children's Cancer Group Cancer 83 1998 2030 2039
9. CH Pui, PS Gaynon, JM Boyett Outcome of treatment in childhood acute lymphoblastic leukaemia with rearrangements of the 11q23 cromosomal region Lancet 359 2002 1909 1915
10. M Aricò, MG Valsecchi, V Conter Improved outcome in high-risk childhood acute lymphoblastic leukaemia defined by prednisone-poor response treated with double Berlin-Frankfurt-Muenster protocol II Blood 100 2002 420 426
11. JB Nachman, N Harland, HN Sather Augmented post induction therapy for children with high risk acute lymphoblastic leukemia and a slow response to initial therapy N Engl J Med 338 1998 1663 1671
12. JP Bordigoni, JP Vernant, G Souillet Allogeneic bone marrow transplantation for children with acute lymphoblastic leukaemia in first remission: a cooperative study of the Groupe d'Etude de la Greffe de Moelle Osseuse J Clin Oncol 7 1989 747 753
13. JM Chessells, C Bailey, K Wheeler, SM Richards Bone marrow transplantation for high-risk childhood lymphoblastic leukaemia in first remission: experience in MRC UKALL X Lancet 340 1992 565 568
14. UM Saarinen, L Mellandewr, K Nysom Allogeneic bone marrow transplantation in first remission for children with very high risk acute lymphoblastic leukaemia: a retrospective case control study in the Nordic countries Bone Marrow Transplant 17 1996 357 363
15. C Uderzo, MG Valsecchi, A Balduzzi Allogeneic bone marrow transplantation versus chemotherapy in high risk childhood acute lymphoblastic leukaemia in first remission Br J Haematol 96 1997 387 394
16. KA Wheeler, SM Richards, CC Bailey Bone marrow transplantation versus chemotherapy in the treatment of very high risk childhood acute lymphoblastic leukaemia in first remission: results from Medical Research Council UKALL X and XI Blood 96 2000 2412 2418
17. A Sharathkumar, EF Saunders, Y Dror Allogeneic bone marrow transplantation vs. chemotherapy for children with Philadelphia chromosome-positive acute lymphoblastic leukaemia Bone Marrow Transplant 33 2004 39 45
18. R Gray, K Wheatley How to avoid bias when comparing bone marrow transplantation with chemotherapy Bone Marrow Transplant 7 1991 9 12
19. MG Valsecchi, G Masera A new challenge in clinical research in childhood ALL: the prospective meta-analysis strategy for Intergroup collaboration Annals Oncol 7 1996 1005 1008
20. JM Lachin, MA Faulkes Evaluation of sample size and power for analyses of survival with allowance of non-uniform patient entry, losses to follow-up, non compliance and stratification Biometrics 42 1986 507 519
21. GD Davey Smith, S Ebrahim Mendelian randomization: can genetic epidemiology contribute to understanding environmental determinants of disease? Int J Epidemiol 32 2003 1 22
22. E Marubini, MG Valsecchi The Cox regression model E Marubini MG Valsecchi Analysing survival data from clinical trials and observational studies 1995 John Wiley Chichester 171 222
23. RJ Gray A class of K-sample tests for comparing the cumulative incidence of a competing risk Ann Stat 16 1988 1141 1154
24. WG Woods, S Neudorf, S Gold A comparison of allogeneic bone marrow transplantation, autologous bone marrow transplantation, and aggressive chemotherapy in children with acute myeloid leukaemia in remission: a report from the Children's Cancer Group Blood 97 2001 56 62
25. S Suciu, F Mandelli, T de Witte Allogeneic compared with autologous stem cell transplantation in the treatment of patients younger than 46 years with acute myeloid leukaemia (AML) in first complete remission (CR1): an intention-to-treat analysis of the EORTC/Gimema AML-10 trial Blood 102 2003 1232 1240
26. M Bleakley, PJ Shaw, JM Nielsen Allogeneic bone marrow transplantation for childhood relapsed acute lymphoblastic leukemia: comparison of outcome in patients with and without a matched family donor Bone Marrow Transplant 30 2002 1 7
27. V Gupta, Q-L Yi, J Brandwein The role of allogeneic bone marrow transplantation in adult patients below the age of 55 years with acute lymphoblastic leukaemia in first complete remission: a donor vs. no donor comparison Bone Marrow Transplant 33 2004 397 404
28. AE Woolfrey, C Anasetti, B Storer Factors associated with outcome after unrelated marrow transplantation for treatment of acute lymphoblastic leukemia in children Blood 99 2002 2002 2008
29. F Locatelli, M Zecca, C Messina Improvement over time in outcome for children with acute lymphoblastic leukaemia in second remission given hematopoietic stem cell transplantation from unrelated donors Leukemia 16 2002 2228 2237
30. UM Saarinen-Pihkala, G Gustafsson, O Ringden No disadvantage in outcome of using matched-unrelated donors compared with matched sibling donors for bone marrow transplantation in children with acute lymphoblastic leukaemia in second remission J Clin Oncol 19 2001 3406 3414
31. FA Al-Kasim, I Thornley, M Rolland Single centre experience with allogeneic bone marrow transplantation for acute lymphoblastic leukemia in childhood: similar survival after matched-related and matched unrelated donor transplants Br J Haematol 116 2002 483 490
32. A Biondi, MG Valsecchi, T Seriu Molecular detection of minimal residual disease is a strong predictive factor of relapse in childhood B-lineage acute lymphoblastic leukaemia with medium risk features: a case control study of the International BFM study group Leukemia 14 2000 1939 1943